drugset / Trial / NCT01822587

Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving

NCT01822587

Phase 2 Completed 181 enrolled Medical University of South Carolina
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators' recently completed study has provided the first evidence that administration of the medication propranolol, following exposure to cocaine cues, can alter drug-associated memories and reduce craving and other drug cue-elicited responses in cocaine addicted persons. The investigators will attempt to augment this effect by a) doubling the number of propranolol-medicated cocaine cue exposure (CCE) retrieval sessions and b) increasing the dose of propranolol. It is expected that propranolol treated groups, relative to placebo treated groups, will evidence greater reduction of craving, cue reactivity and cocaine use during follow-up cocaine cue exposures. Also, these effects will be greater for those who receive 80mg of propranolol as opposed to 40mg.

Timeline

Start
2013-09
Primary completion
2018-11-05
Completion
2018-11-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propranolol Small molecule 40 mg Oral
Comparator Propranolol Small molecule 80 mg Oral

Indications